Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Deferred Tax Assets / Liabilities ₹4.98 Cr₹4.42 Cr₹4.58 Cr₹7.16 Cr₹5.85 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹4.98 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹4.98 Cr
Mar2023₹4.42 Cr
Mar2022₹4.58 Cr
Mar2017₹7.16 Cr
Mar2016₹5.85 Cr

How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹4.98 Cr
12.55
Mar2023 ₹4.42 Cr
-3.34
Mar2022 ₹4.58 Cr
-36.07
Mar2017 ₹7.16 Cr
22.41
Mar2016 ₹5.85 Cr -

Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹2,003.1 Cr -3.3% 21.7% 73.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,420.0 Cr -0.2% -2.9% 12.6% Stock Analytics
DIVIS LABORATORIES ₹177,572.0 Cr 0.3% 6.5% 49% Stock Analytics
CIPLA ₹123,329.0 Cr 1.1% 1.8% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,396.0 Cr -0.2% 9.5% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,956.0 Cr 1.9% 0.4% 14% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-3.3%

21.7%

73.7%

SENSEX

-0.8%

-0.9%

6.9%


You may also like the below Video Courses